OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,227 | +34.4% | 1,152 | -1.7% | 0.00% | – |
| Q2 2023 | $10,583 | +10378.2% | 1,172 | -96.0% | 0.00% | -100.0% |
| Q1 2023 | $101 | +320.8% | 29,150 | +197.7% | 0.00% | +200.0% |
| Q4 2022 | $24 | -99.9% | 9,792 | +32.7% | 0.00% | – |
| Q3 2022 | $20,000 | -39.4% | 7,378 | -9.2% | 0.00% | -100.0% |
| Q2 2022 | $33,000 | +32.0% | 8,126 | +36.4% | 0.00% | – |
| Q1 2022 | $25,000 | -60.9% | 5,956 | -13.3% | 0.00% | -100.0% |
| Q4 2021 | $64,000 | +611.1% | 6,871 | +1988.4% | 0.00% | – |
| Q3 2021 | $9,000 | -73.5% | 329 | -73.2% | 0.00% | -100.0% |
| Q2 2021 | $34,000 | -12.8% | 1,229 | +5.2% | 0.00% | 0.0% |
| Q1 2021 | $39,000 | +44.4% | 1,168 | +104.9% | 0.00% | 0.0% |
| Q4 2020 | $27,000 | – | 570 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 7,803,600 | $96,374,460 | 6.54% |
| Logos Global Management LP | 3,743,875 | $46,236,856 | 6.17% |
| MPM BioImpact LLC | 1,857,681 | $22,942,360 | 6.12% |
| Cormorant Asset Management, LP | 4,504,764 | $55,633,835 | 3.24% |
| BVF INC/IL | 9,135,893 | $112,828,279 | 3.04% |
| Vivo Capital, LLC | 1,873,704 | $23,140,244 | 2.54% |
| Altium Capital Management LP | 335,000 | $4,137,250 | 2.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 407,801 | $5,036,342 | 1.53% |
| HighVista Strategies LLC | 247,880 | $3,061,318 | 1.42% |
| ACUTA CAPITAL PARTNERS, LLC | 153,007 | $1,889,636 | 1.27% |